A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)

NCT02318277 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Head and Neck Cancer
Lung Cancer
UC (Urothelial Cancer)

Interventions

DRUG: MEDI4736
DRUG: INCB024360

Sponsor

Incyte Corporation

Collaborators

[object Object]